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The mechanisms regulating altered airway smooth muscle
(ASM) cell tone and airway reactivity in asthma remain
incompletely understood. For vascular smooth muscle
(VSM), the most important endogenous relaxation path-
way is the nitric oxide (NO)-guanylate cyclase-cyclic
GMP-dependent protein kinase type I (PKGI) pathway in
which endogenous NO from NO synthases or from exog-
enous nitrovasodilators activate guanylate cyclase,
increasing cGMP levels, and activating PKGI. PKGI in turn
targets specific VSM molecules that mediate smooth mus-
cle relaxation. Recent evidence supports that in ASM, like
in VSM, activators of guanylyl cyclases have significant
cGMP-mediated relaxant and antiproliferative effects.
PKGI is therefore a prime but unexplored candidate mol-
ecule to mediate ASM relaxation. Recently, we have used
mice harbouring a mutation in the leucine zipper N-ter-
minal interaction domain (LZM mice [1]) to test the
hypothesis that PKGIα is a critical mediator of ASM relax-
ation that normally protects against airway hyperrespon-
sivity via interactions with specific molecular targets,
including ASM myosin phosphate and Rho/Rho-kinase,
and that this regulatory system is perturbed in the setting
of asthma. Using this knock-in mouse harboring a discrete
mutation in the protein-protein interaction domain of
PKGI, which disrupts NO-PKG-mediated smooth muscle
relaxation by disrupting the PKGI-myosin phosphatase
complex we have begun to explore the mechanism of
PKGI-mediated ASM relaxation and the role of PKGI in
models of asthma. Several asthma studies in LZM mice
and WT littermates have now been performed and ana-
lyzed using both the acute and the chronic House Dust
Mite (HDM) asthma model in WT and LZM mice. End-
points examined include airway responsiveness to metha-
choline; quantification of inflammatory cell populations
from Bronchoalveolar lavage (BAL); and studies of airway
smooth muscle in the mice. In the LZM mice, there is a
significant increase in bronchospasm noted in the airways
of mutant mice in both acute and chronic asthma models.
No differences between WT and LZM mice in the extent of
increase in either total cells or in eosinophilia in BALF
samples following HDM was noted in the either the acute
or chronic models. The extent and volume of Airway SMC
a-actin was also measured in the WT and LZM mice fol-
lowing HDM-induced asthma in the acute model. SMC
labeling in the airways was quantified using immunohis-
tochemistry and computerized morphometrics and for
each measure, a significant increase in SMC number and
total volume was noted in the LZM mice. Studies of PKG
expression level and of SMC proliferation in the asthma
models are underway. These experiments will provide bet-
ter understanding of ASM relaxation at the molecular level
and have the potential to identify novel gene targets for
the development of new therapeutic approaches to bron-
choconstriction in asthma.
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